NVO NYSE · Healthcare · FY 2025-12-31

NOVO NORDISK A S

Back to NYSE
0.083.5166.9250.4333.9ABVfair 14.40buy ≤ 7.92EPVfair 244.89buy ≤ 110.20EBVfair 150.43buy ≤ 82.74DBVfair 213.88buy —price 309.13 DKK
0.012.725.438.150.8ABVfair 2.19buy ≤ 1.21EPVfair 37.30buy ≤ 16.78EBVfair 22.91buy ≤ 12.60DBVfair 32.57buy —price 47.08 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in DKKUSD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Franchise
Confidence
●○○ Low · 4/4
Price
309.1347.080 DKKUSD *
Market cap
1373.60B209.20B DKKUSD *
P / B
7.08
P / E
13.42
EPS
23.0303.507
DPS / yield
12.2061.859 (3.9%)
NAV / share
14.4022.193
Graham number
150.4322.910
Z'' score
2.90
Piotroski F
4 / 9
Beneish M
-2.56
ROIC vs WACC
35.4% vs 6.5%

* Listed in USD — the pipeline states price and all valuations in the filing currency DKK (fx 6.57 DKK/USD).

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.